Indian Drugmaker Glenmark Conducts Clinical Trials On Favipiravir, Potential COVID-19 Drug

Glenmark's Clinical Trials On Favipiravir Potential Treatment for
COVID-19 In India, clinical trials on Favipiravir Antiviral tablets
for Covid-19 patients begins after the regulator (DCGI) gave approval
for an Indian drugmaker to proceed. An integrated global and
research-led pharmaceutical company, Glenmark Pharmaceuticals Ltd.
announced that it has got approval to conduct trials with the drug […]

The post Indian Drugmaker Glenmark Conducts Clinical Trials On
Favipiravir, Potential COVID-19 Drug appeared first on BioTecNika .

https://www.biotecnika.org/2020/04/glenmarks-clinical-trials-on-favipiravir-potential-treatment-for-covid-19/

Biotech News